The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: Comment on the editorial by Harris [1]

Johannes W G Jacobs*, Maarten Boers, John R. Kirwan, Johannes W J Bijlsma

*Corresponding author for this work

    Research output: Contribution to journalLetter (Academic Journal)peer-review

    4 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)2031-2032
    Number of pages2
    JournalArthritis and Rheumatism
    Issue number6
    Publication statusPublished - 1 Jun 2006

    Cite this